Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $457.24 thousand as of April 28, 2026. Its market cap has increased by 10.18% in one year.

Market Cap

457.24K

Enterprise Value

1.24M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.07

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 457.24K, a decrease of -99.73%. That is a compound annual growth rate of -39.68%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	440.09K	-16.75%
Dec 31, 2025	528.62K	40.64%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hepion Pharmaceuticals	721.10K
SQZ Biotechnologies Company	707.79K
Emmaus Life Sciences	624.68K
Eloxx Pharmaceuticals	608.63K
Regenerative Medical Technology Group	525.56K
Bio-Path Holdings	521.76K
EV Biologics	511.27K
CNBX Pharmaceuticals	490.31K

Market Cap Rankings